Form D · Pharmaceuticals
Ionetix Corp / DE /
Lansing, MI · CIK 0002108121
Offering snapshot reported Apr 23, 2026 · SEC filing
- Reported sold
- $32.3M Offering amount: $32.3M
- Investors reported
- 267 Form D · investor count
- Minimum accepted
- $100K Reported outside-investor minimum
- First sale
- Apr 9, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 23, 2026 | Initial | $32,331,837 | No comparison | 267 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $2.59M
- Finders' fees
- $0
- Form D file number
- 021-581658
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| None | None | Network 1 Financial Securities, Inc. · CRD 000013577 |
Source: Form D, filed Apr 23, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Douglas Boothe | Director |
| Kevin Cameron | Executive |
| David Landskowsky | Director |
| Gregory Martin | Director |
| Phieu Phun | Executive |
| Michael Stewart | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
3130 Sovereign Drive, Suite 5 D
Lansing, MI, 48911
Phone: 517-752-4069
Lansing, MI, 48911
Phone: 517-752-4069